novel synthetic tcr and antigen receptor (star) t-cell therapy for b-all
Published 2 years ago • 164 plays • Length 5:14Download video MP4
Download video MP3
Similar videos
-
2:49
identifying novel antigens for tcr t-cell therapy
-
2:10
driving the identification of novel t cell therapies
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
1:34
cctx-001: a novel car-t therapy for aml
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
1:10
cell expansion and vector design in novel t-cell therapies
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
4:17
novel car t-cell therapies for hematological malignancies: exploring new targets
-
2:16
evaluating the safety and efficacy of novel anti-cd7 universal car-t therapy in r/r t-all and t-lbl
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
7:55
tcr gene rearrangements
-
2:41
cell avidity as a predictor of t-cell efficacy
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:13
an insight into novel third-generation tlr2 co-stimulatory car-t cells
-
4:20
utilizing neoantigen-specific tcrs for personalized immunotherapies
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies